Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Ischemic Heart Disease

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 126 articles: HTML format

Single Articles

May 2020
1. FINUCANE TE
   Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
   Ann Intern Med. 2020;172:707.
   PubMed    
   
   
   
2. PARK S, Han K, Kim DK
   Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
   Ann Intern Med. 2020;172:707-708.
   PubMed    
   
   
   April 2020
3. BACH RG
   Low-dose colchicine after MI reduced a composite ischemic cardiovascular outcome vs placebo.
   Ann Intern Med. 2020;172:JC39.
   PubMed    
   
   
   March 2020
4. KLOECKER DE, Davies MJ, Khunti K, Zaccardi F, et al
   Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes.
   Ann Intern Med. 2020 Mar 24. pii: 2763641. doi: 10.7326/M19-3286.
   PubMed     Abstract available
   
   
   
5. KHAN SU, Osman M, Khan MU, Khan MS, et al
   Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
   Ann Intern Med. 2020 Mar 17. pii: 2763089. doi: 10.7326/M19-3763.
   PubMed     Abstract available
   
   
   
6. DOHERTY JU
   Combined Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Navigating Between Scylla and Charybdis.
   Ann Intern Med. 2020 Mar 17. pii: 2763091. doi: 10.7326/M20-0572.
   PubMed    
   
   
   January 2020
7. RANASINGHE I, Hossain S, Ganesan A, Krumholz HM, et al
   Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation.
   Ann Intern Med. 2020;172:166-167.
   PubMed    
   
   
   
8. EMAMI M, Wong CX, Tu S, Sanders P, et al
   Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation.
   Ann Intern Med. 2020;172:166.
   PubMed    
   
   
   
9. SANTULLI G
   In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet.
   Ann Intern Med. 2020;172:JC6.
   PubMed    
   
   
   
10. HUDSON M
    In suspected AMI, an extended algorithm increased sensitivity and decreased specificity for predicting 30-day MACE.
    Ann Intern Med. 2020;172:JC11.
    PubMed    
    
    
    
11. RACO DL
    In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.
    Ann Intern Med. 2020;172:JC5.
    PubMed    
    
    
    
12. RACO DL
    In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.
    Ann Intern Med. 2020;172:JC4.
    PubMed    
    
    
    
13. CORNELL JE, Mulrow CD
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:75.
    PubMed    
    
    
    
14. MAYER M
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:74.
    PubMed    
    
    
    
15. KIVELA JM
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:73-74.
    PubMed    
    
    
    
16. BELL KJL, Semsarian C, Doust J
    Why We Might Not Need to Stress About Ruling Out Inducible Myocardial Ischemia.
    Ann Intern Med. 2020 Jan 7. pii: 2758510. doi: 10.7326/M19-3731.
    PubMed    
    
    
    
17. WALTER J, du Fay de Lavallaz J, Koechlin L, Zimmermann T, et al
    Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study.
    Ann Intern Med. 2020 Jan 7. pii: 2758509. doi: 10.7326/M19-0080.
    PubMed     Abstract available
    
    
    December 2019
18. DUCEPPE E, Patel A, Chan MTV, Berwanger O, et al
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort Study.
    Ann Intern Med. 2019 Dec 24. pii: 2758032. doi: 10.7326/M19-2501.
    PubMed     Abstract available
    
    
    
19. QAMAR A, Bangalore S
    Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time?
    Ann Intern Med. 2019 Dec 24. pii: 2758034. doi: 10.7326/M19-3718.
    PubMed    
    
    
    
20. 
    Correction: Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2019 Dec 17. pii: 2757635. doi: 10.7326/L19-0721.
    PubMed    
    
    
    
21. DODSON JA, Hajduk AM, Geda M, Krumholz HM, et al
    Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study.
    Ann Intern Med. 2019 Dec 10. pii: 2757402. doi: 10.7326/M19-0974.
    PubMed     Abstract available
    
    
    
22. KAZI DS, Bibbins-Domingo K
    Accurately Predicting Cardiovascular Risk-and Acting on It.
    Ann Intern Med. 2019 Dec 10. pii: 2757420. doi: 10.7326/M19-3662.
    PubMed    
    
    
    
23. DOXEY R
    Stable Ischemic Heart Disease.
    Ann Intern Med. 2019;171:862-863.
    PubMed    
    
    
    November 2019
24. PARK S, Lee S, Kim Y, Lee Y, et al
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.
    Ann Intern Med. 2019 Nov 26. pii: 2756142. doi: 10.7326/M19-0563.
    PubMed     Abstract available
    
    
    
25. 
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2019 Nov 26. pii: 2756144. doi: 10.7326/P19-0016.
    PubMed    
    
    
    
26. CHESKIN LJ, Slavin M
    Review: No high-certainty evidence exists that nutritional supplements or diets affect cardiovascular outcomes.
    Ann Intern Med. 2019;171:JC50.
    PubMed    
    
    
    October 2019
27. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Preventing Coronary Disease in Rheumatoid Arthritis: Do Guidelines Apply?
    Ann Intern Med. 2019;171:CG1.
    PubMed    
    
    
    
28. COHEN JB, Denker MG, Cohen DL, Townsend RR, et al
    Cardiovascular Events and Mortality in White Coat Hypertension.
    Ann Intern Med. 2019;171:603-604.
    PubMed    
    
    
    
29. ZHANG ZY, Asayama K, Franklin SS, Thijs L, et al
    Cardiovascular Events and Mortality in White Coat Hypertension.
    Ann Intern Med. 2019;171:602-603.
    PubMed    
    
    
    
30. BELLO NA, Miller EC, Cleary KL, Wapner R, et al
    Cases in Precision Medicine: A Personalized Approach to Stroke and Cardiovascular Risk Assessment in Women.
    Ann Intern Med. 2019 Oct 15. pii: 2753022. doi: 10.7326/M19-1601.
    PubMed     Abstract available
    
    
    
31. BATES ER
    In patients with suspected AMI and LBBB, algorithms based on ECG and troponin data were tested to rule MI in or out.
    Ann Intern Med. 2019;171:JC47.
    PubMed    
    
    
    
32. BATES ER
    In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes.
    Ann Intern Med. 2019;171:JC46.
    PubMed    
    
    
    September 2019
33. SELAK V, Jackson R, Poppe K, Wu B, et al
    Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis.
    Ann Intern Med. 2019 Sep 17. pii: 2751452. doi: 10.7326/M19-1132.
    PubMed     Abstract available
    
    
    August 2019
34. KATZ D, Gavin MC
    Stable Ischemic Heart Disease.
    Ann Intern Med. 2019;171:ITC17-ITC32.
    PubMed     Abstract available
    
    
    July 2019
35. RANASINGHE I, Labrosciano C, Horton D, Ganesan A, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study.
    Ann Intern Med. 2019 Jul 30. pii: 2739788. doi: 10.7326/M18-2810.
    PubMed     Abstract available
    
    
    
36. O'BRIEN CW, Juraschek SP, Wee CC
    Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey.
    Ann Intern Med. 2019 Jul 23. pii: 2738925. doi: 10.7326/M19-0953.
    PubMed    
    
    
    
37. VALLABHAJOSYULA S, Bell MR
    Immediate and delayed coronary angiography did not differ for survival after OHCA without STEMI.
    Ann Intern Med. 2019;171:JC4.
    PubMed    
    
    
    
38. PANAGIOTOU OA, Kumar A, Gutman R, Keohane LM, et al
    Hospital Readmission Rates in Medicare Advantage and Traditional Medicare: A Retrospective Population-Based Analysis.
    Ann Intern Med. 2019;171:99-106.
    PubMed     Abstract available
    
    
    
39. KHAN SU, Khan MU, Riaz H, Valavoor S, et al
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map.
    Ann Intern Med. 2019 Jul 9. pii: 2737825. doi: 10.7326/M19-0341.
    PubMed     Abstract available
    
    
    
40. YEBYO HG, Aschmann HE, Puhan MA
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:74-76.
    PubMed    
    
    
    
41. DJULBEGOVIC B, Hozo I
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:73-74.
    PubMed    
    
    
    
42. ZHOU Z
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:73.
    PubMed    
    
    
    
43. SPENCE JD
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:72-73.
    PubMed    
    
    
    
44. SORUM PC
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:74.
    PubMed    
    
    
    
45. GOOD CB, Hernandez I, Parekh N
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:72.
    PubMed    
    
    
    June 2019
46. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Length of Stay After Myocardial Infarction: How Low Can We Go?
    Ann Intern Med. 2019;170:CG1.
    PubMed    
    
    
    
47. CENTOR RM, Blaha MJ
    Web Exclusive. Annals On Call - Coronary Artery Calcium Testing.
    Ann Intern Med. 2019;170:OC1.
    PubMed    
    
    
    
48. BATES ER
    After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placebo.
    Ann Intern Med. 2019;170:JC62.
    PubMed    
    
    
    
49. KIRSCHNER JM, Hunter BR
    In normoxemic suspected MI, oxygen therapy did not reduce all-cause mortality or HF hospitalization at 2 years.
    Ann Intern Med. 2019;170:JC63.
    PubMed    
    
    
    
50. COHEN JB, Lotito MJ, Trivedi UK, Denker MG, et al
    Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2019 Jun 11. pii: 2735719. doi: 10.7326/M19-0223.
    PubMed     Abstract available
    
    
    
51. GRUNDY SM, Stone NJ
    2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.
    Ann Intern Med. 2019;170:779-783.
    PubMed     Abstract available
    
    
    May 2019
52. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Cardiovascular Risk, Blood Pressure, and Cognition in a Patient With Diabetes.
    Ann Intern Med. 2019;170:CG1.
    PubMed    
    
    
    
53. SCHECTMAN JM
    Review: In adults, general health checks do not reduce all-cause, cardiovascular, or cancer mortality.
    Ann Intern Med. 2019;170:JC52.
    PubMed    
    
    
    April 2019
54. BRAND A, Gao L, Hamann A, Crayen C, et al
    Medical Graphic Narratives to Improve Patient Comprehension and Periprocedural Anxiety Before Coronary Angiography and Percutaneous Coronary Intervention: A Randomized Trial.
    Ann Intern Med. 2019 Apr 9. pii: 2730521. doi: 10.7326/M18-2976.
    PubMed    
    
    
    March 2019
55. AVIV A
    Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer.
    Ann Intern Med. 2019;170:356.
    PubMed    
    
    
    
56. O'GLASSER AY
    Regarding Marcia.
    Ann Intern Med. 2019;170:346-347.
    PubMed    
    
    
    February 2019
57. SELAK V, Jackson R, Poppe K, Wu B, et al
    Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study.
    Ann Intern Med. 2019 Feb 26. pii: 2726667. doi: 10.7326/M18-2808.
    PubMed     Abstract available
    
    
    
58. LU J, Lu Y, Yang H, Bilige W, et al
    Characteristics of High Cardiovascular Risk in 1.7 Million Chinese Adults.
    Ann Intern Med. 2019 Feb 19. pii: 2725144. doi: 10.7326/M18-1932.
    PubMed     Abstract available
    
    
    
59. WHELTON PK, Colantonio LD
    Cardiovascular Disease Risk Estimation in China.
    Ann Intern Med. 2019 Feb 19. pii: 2725146. doi: 10.7326/M18-3301.
    PubMed    
    
    
    
60. BELL KJL, Doust J, Glasziou P, Cullen L, et al
    Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?
    Ann Intern Med. 2019;170:259-261.
    PubMed    
    
    
    
61. KAZI DS, Penko J, Coxson PG, Guzman D, et al
    Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
    Ann Intern Med. 2019;170:221-229.
    PubMed     Abstract available
    
    
    
62. CARDOSO R, Nasir K, Blumenthal RS, Blaha MJ, et al
    Selective Use of Coronary Artery Calcium Testing for Shared Decision Making: Guideline Endorsed and Ready for Prime Time.
    Ann Intern Med. 2019 Feb 12. pii: 2724340. doi: 10.7326/M18-3675.
    PubMed    
    
    
    January 2019
63. JORGE A, Wallace ZS, Lu N, Zhang Y, et al
    Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study.
    Ann Intern Med. 2019 Jan 22. pii: 2722549. doi: 10.7326/M18-1570.
    PubMed     Abstract available
    
    
    
64. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Low Risk for Postoperative Myocardial Infarction: What Do We Really Know?
    Ann Intern Med. 2019;170:CG1.
    PubMed    
    
    
    
65. GOODMAN M, Getahun D, Silverberg MJ, Safer J, et al
    Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.
    Ann Intern Med. 2019;170:143.
    PubMed    
    
    
    
66. GOLDSTEIN Z, Streed C, Resiman T, Mukherjee M, et al
    Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.
    Ann Intern Med. 2019;170:142-143.
    PubMed    
    
    
    
67. FURLAN S, Borzak S
    After PCI with 2nd-generation DESs for STEMI, dual-antiplatelet therapy for 6 mo was noninferior to 12 mo.
    Ann Intern Med. 2019;170:JC6.
    PubMed    
    
    
    
68. SULLIVAN K, Van Spall HGC
    A wearable cardioverter-defibrillator did not reduce arrhythmic death in MI with reduced ejection fraction.
    Ann Intern Med. 2019;170:JC5.
    PubMed    
    
    
    
69. THOMAS NJ
    Physician, Heal Thyself.
    Ann Intern Med. 2019;170:135.
    PubMed    
    
    
    
70. KAUFMAN TM, Fazio S, Shapiro MD
    Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?
    Ann Intern Med. 2019 Jan 8. pii: 2720158. doi: 10.7326/M18-3009.
    PubMed    
    
    
    December 2018
71. HUDSON MP
    Coronary CTA reduced risk for coronary events at 5 years in patients with stable chest pain.
    Ann Intern Med. 2018;169:JC70.
    PubMed    
    
    
    
72. GILBERT MP, Bain SC, Franek E, Jodar-Gimeno E, et al
    Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.
    Ann Intern Med. 2018 Dec 4. pii: 2717732. doi: 10.7326/M18-1569.
    PubMed    
    
    
    
73. YEBYO HG, Aschmann HE, Puhan MA
    Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Ann Intern Med. 2018 Dec 4. pii: 2717730. doi: 10.7326/M18-1279.
    PubMed     Abstract available
    
    
    
74. 
    Benefits and Harms of Using Statins to Prevent Cardiovascular Disease.
    Ann Intern Med. 2018 Dec 4. pii: 2717123. doi: 10.7326/P18-0019.
    PubMed    
    
    
    November 2018
75. BATES ER
    Review: In coronary artery disease, PCI reduces 30-day and 5-year risk for stroke compared with CABG.
    Ann Intern Med. 2018;169:JC55.
    PubMed    
    
    
    
76. SMITH DA
    Review: In adults, increasing omega-6 fatty acid intake does not reduce mortality or overall cardiovascular events.
    Ann Intern Med. 2018;169:JC51.
    PubMed    
    
    
    
77. SMITH DA
    Review: Long-chain omega-3 fatty acids have no effect on mortality or overall cardiovascular events.
    Ann Intern Med. 2018;169:JC50.
    PubMed    
    
    
    
78. CENTOR RM, Hayward RA
    Web Exclusive. Annals On Call - Improving Estimation of Cardiovascular Risk.
    Ann Intern Med. 2018;169:OC1.
    PubMed    
    
    
    
79. DEVEREAUX PJ
    The Potential for Troponin to Inform Prognosis in Patients With Stable Coronary Artery Disease.
    Ann Intern Med. 2018 Nov 6. pii: 2712931. doi: 10.7326/M18-2984.
    PubMed    
    
    
    
80. HAMMADAH M, Kim JH, Tahhan AS, Kindya B, et al
    Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study.
    Ann Intern Med. 2018 Nov 6. pii: 2712482. doi: 10.7326/M18-0670.
    PubMed     Abstract available
    
    
    October 2018
81. GROSSO G, Sippl N, Kjellstrom B, Amara K, et al
    Antiphospholipid Antibodies in Patients With Myocardial Infarction.
    Ann Intern Med. 2018 Oct 23. pii: 2709123. doi: 10.7326/M18-2130.
    PubMed    
    
    
    August 2018
82. 
    Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors.
    Ann Intern Med. 2018;169:270-271.
    PubMed    
    
    
    
83. MAI LM, Oczkowski W
    Tenecteplase before thrombectomy for ischemic stroke improved reperfusion compared with alteplase.
    Ann Intern Med. 2018;169:JC20.
    PubMed    
    
    
    July 2018
84. LIU P, Dhruva SS, Shah ND, Ross JS, et al
    Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.
    Ann Intern Med. 2018 Jul 24. pii: 2694805. doi: 10.7326/M18-0965.
    PubMed    
    
    
    
85. GETAHUN D, Nash R, Flanders WD, Baird TC, et al
    Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
    Ann Intern Med. 2018 Jul 10. pii: 2687653. doi: 10.7326/M17-2785.
    PubMed     Abstract available
    
    
    
86. STUART JJ, Tanz LJ, Missmer SA, Rimm EB, et al
    Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study.
    Ann Intern Med. 2018 Jul 3. pii: 2686987. doi: 10.7326/M17-2740.
    PubMed     Abstract available
    
    
    
87. FRASER A
    Women's Cardiovascular Health After a Hypertensive Disorder of Pregnancy.
    Ann Intern Med. 2018 Jul 3. pii: 2686988. doi: 10.7326/M18-1443.
    PubMed    
    
    
    
88. 
    High Blood Pressure During Pregnancy and Development of Risk Factors for Cardiovascular Disease.
    Ann Intern Med. 2018 Jul 3. pii: 2686989. doi: 10.7326/P18-0008.
    PubMed    
    
    
    June 2018
89. BATES ER
    Review: In CAD, CABG reduced 5-year mortality more than PCI in multivessel but not left main disease.
    Ann Intern Med. 2018;168:JC66.
    PubMed    
    
    
    
90. DEFILIPPIS AP, Trainor P
    When Given a Lemon, Make Lemonade: Revising Cardiovascular Risk Prediction Scores.
    Ann Intern Med. 2018 Jun 5. pii: 2683614. doi: 10.7326/M18-1175.
    PubMed    
    
    
    
91. YADLOWSKY S, Hayward RA, Sussman JB, McClelland RL, et al
    Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk.
    Ann Intern Med. 2018 Jun 5. pii: 2683613. doi: 10.7326/M17-3011.
    PubMed     Abstract available
    
    
    May 2018
92. EBERT BL, Libby P
    Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers.
    Ann Intern Med. 2018 May 29. pii: 2683000. doi: 10.7326/M18-0737.
    PubMed    
    
    
    
93. STAMATELOPOULOS K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, et al
    Amyloid-beta (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.
    Ann Intern Med. 2018 May 22. pii: 2681795. doi: 10.7326/M17-1540.
    PubMed     Abstract available
    
    
    
94. GOEL A
    Efficacy and safety of ticagrelor were similar in patients with past MI, regardless of multivessel coronary disease.
    Ann Intern Med. 2018;168:JC56.
    PubMed    
    
    
    
95. PERZYNSKI AT, Rothberg MB, Dawson NV, Coulton CJ, et al
    Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position.
    Ann Intern Med. 2018;168:681-682.
    PubMed    
    
    
    
96. SPENCE JD
    Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position.
    Ann Intern Med. 2018;168:680-681.
    PubMed    
    
    
    April 2018
97. CHAMBERLAIN JJ, Johnson EL, Leal S, Rhinehart AS, et al
    Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.
    Ann Intern Med. 2018 Apr 3. pii: 2677350. doi: 10.7326/M18-0222.
    PubMed     Abstract available
    
    
    March 2018
98. BROWN AF, Liang LJ, Vassar SD, Escarce JJ, et al
    Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014.
    Ann Intern Med. 2018 Mar 20. pii: 2675356. doi: 10.7326/M17-0996.
    PubMed     Abstract available
    
    
    
99. MENSAH GA
    The Black-White Cardiovascular Health Disparity Is Narrowing, But Not for the Reason You Think.
    Ann Intern Med. 2018 Mar 20. pii: 2675357. doi: 10.7326/M18-0349.
    PubMed    
    
    
    February 2018
100. GRANT PJ, Eagle KA
     Annals for Hospitalists Inpatient Notes - Perioperative Medicine-The Past, Present, and Future of Cardiovascular Risk Assessment and Risk Reduction Strategies.
     Ann Intern Med. 2018;168:HO2-HO3.
     PubMed    
     
     
     January 2018
101. RAVI D, Ghasemiesfe M, Korenstein D, Cascino T, et al
     Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review.
     Ann Intern Med. 2018 Jan 23. pii: 2670319. doi: 10.7326/M17-1548.
     PubMed     Abstract available
     
     
     
102. MANCINI GBJ
     Comparison Shopping: Guidelines for Statins for Primary Prevention of Cardiovascular Disease.
     Ann Intern Med. 2018 Jan 2. pii: 2667697. doi: 10.7326/M17-2917.
     PubMed    
     
     
     December 2017
103. LIPSCOMBE LL
     Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes.
     Ann Intern Med. 2017;167:JC67.
     PubMed    
     
     
     
104. SUNDARARAJAN V, Vogrin S
     Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.
     Ann Intern Med. 2017;167:836.
     PubMed    
     
     
     
105. OSHIMA Y, Morishima Y, Ono K, Hirano M, et al
     Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.
     Ann Intern Med. 2017;167:836.
     PubMed    
     
     
     
106. KOPIN L, Lowenstein C
     Dyslipidemia.
     Ann Intern Med. 2017;167:ITC81-ITC96.
     PubMed     Abstract available
     
     
     November 2017
107. O'DONOGHUE FJ, McDonald CF
     Review: In obstructive sleep apnea, continuous positive airway pressure does not reduce cardiovascular outcomes.
     Ann Intern Med. 2017;167:JC55.
     PubMed    
     
     
     
108. O'DONOGHUE FJ, McDonald CF
     Review: In adults with sleep apnea, positive airway pressure does not reduce cardiovascular events or death.
     Ann Intern Med. 2017;167:JC54.
     PubMed    
     
     
     
109. PICCOLO R, Windecker S
     Low-Dose Aspirin to Reduce the Risk for Myocardial Infarction Among Patients With Coronary Stents Undergoing Noncardiac Surgery.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2954.
     PubMed    
     
     
     
110. GRAHAM MM, Sessler DI, Parlow JL, Biccard BM, et al
     Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2341.
     PubMed     Abstract available
     
     
     
111. NIEUWSMA JA, Williams JW Jr, Namdari N, Washam JB, et al
     Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression: A Systematic Review.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-1811.
     PubMed     Abstract available
     
     
     
112. DAVIDSON KW, Wasson LT, Kronish IM
     Should You Screen for and Manage Depression in Patients With a Recent Acute Coronary Syndrome? Evidence-Based Answers.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2831.
     PubMed    
     
     
     
113. GO AS, Singer DE, Toh S, Cheetham TC, et al
     Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M16-1157.
     PubMed     Abstract available
     
     
     
114. ZHANG XL, Zhu QQ, Kang LN, Li XL, et al
     Mid- and Long-Term Outcome Comparisons of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis.
     Ann Intern Med. 2017;167:642-654.
     PubMed     Abstract available
     
     
     October 2017
115. 
     Correction: Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection.
     Ann Intern Med. 2017;167:528.
     PubMed    
     
     
     September 2017
116. DHARMARAJAN K, McNamara RL, Wang Y, Masoudi FA, et al
     Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling.
     Ann Intern Med. 2017 Sep 26. doi: 10.7326/M16-2871.
     PubMed     Abstract available
     
     
     
117. BAKER DW
     Age-Related Differences in Hospital Quality of Care for Acute Myocardial Infarction: Getting to the Heart of the Matter.
     Ann Intern Med. 2017 Sep 26. doi: 10.7326/M17-2363.
     PubMed    
     
     
     
118. QUINN T
     Review: Real-world use of nonsteroidal antiinflammatory drugs is associated with acute myocardial infarction.
     Ann Intern Med. 2017;167:JC30.
     PubMed    
     
     
     
119. WORSTER A, Kavsak P
     4 hs-cTnI algorithms had high sensitivity and low failure rates for ruling out acute MI in the ED.
     Ann Intern Med. 2017;167:JC35.
     PubMed    
     
     
     
120. WORSTER A, Kavsak P
     High-STEACS Algorithm missed fewer patients with acute MI than the ESC Pathway in the ED.
     Ann Intern Med. 2017;167:JC34.
     PubMed    
     
     
     
121. LOWENSTERN A, Newby LK
     In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin + clopidogrel reduced adverse events.
     Ann Intern Med. 2017;167:JC28.
     PubMed    
     
     
     August 2017
122. RYMER JA, Granger CB
     Review: A single hs-cTnT with a cutpoint < limit of detection plus a nonischemic ECG can rule out acute MI.
     Ann Intern Med. 2017;167:JC23.
     PubMed    
     
     
     July 2017
123. SCHATTNER A
     Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure.
     Ann Intern Med. 2017;167:JC8.
     PubMed    
     
     
     April 2017
124. KUSSMAUL III WG
     The Single High-Sensitivity Serum Cardiac Troponin Level: A Significant Advance for Chest Pain Pathways?
     Ann Intern Med. 2017 Apr 18. doi: 10.7326/M17-0919.
     PubMed    
     
     
     February 2017
125. BATES ER
     In left main CAD, PCI with everolimus-eluting stents was noninferior to CABG for death, MI, or stroke at 3 years.
     Ann Intern Med. 2017;166:JC21.
     PubMed    
     
     
     
126. BATES ER
     In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI.
     Ann Intern Med. 2017;166:JC20.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: